| COVID‐19 in cancer patients on active systemic therapy–outcomes from LMIC scenario with an emphasis on need for active treatment A Ramaswamy, L Nayak, N Roy Moulik, M Sengar, G Chinnaswamy, ... Cancer Medicine 9 (23), 8747-8753, 2020 | 37 | 2020 |
| Daratumumab at the frontiers of post-transplant refractory T-acute lymphoblastic leukemia—a worthwhile strategy? A Bonda, S Punatar, A Gokarn, A Mohite, K Shanmugam, L Nayak, ... Bone Marrow Transplantation 53 (11), 1487-1489, 2018 | 34 | 2018 |
| ALK positive lung cancer: clinical profile, practice and outcomes in a developing country V Noronha, A Ramaswamy, VM Patil, A Joshi, A Chougule, S Kane, ... PLoS One 11 (9), e0160752, 2016 | 32 | 2016 |
| Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol A Rajendra, H Jain, VNA Bonda, L Nayak, P Tembhare, D Shetty, J Thorat, ... Blood advances 5 (5), 1178-1193, 2021 | 25 | 2021 |
| Infection prevalence in adolescents and adults with acute myeloid leukemia treated in an Indian tertiary care center H Jain, K Rengaraj, V Sharma, A Bonda, R Chanana, J Thorat, A Ronghe, ... JCO Global Oncology 6, 1684-1695, 2020 | 24 | 2020 |
| Use of leflunomide for treatment of cytomegalovirus infection in recipients of allogeneic stem cell transplant A Gokarn, A Toshniwal, A Pathak, S Arora, A Bonda, S Punatar, L Nayak, ... Biology of Blood and Marrow Transplantation 25 (9), 1832-1836, 2019 | 20 | 2019 |
| Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context N Patkar, C Kakirde, P Bhanshe, S Joshi, S Chaudhary, Y Badrinath, ... Frontiers in Oncology 9, 450, 2019 | 20 | 2019 |
| Outcomes of COVID-19 and risk factors in patients with cancer M Sengar, G Chinnaswamy, P Ranganathan, A Ashok, S Bhosale, ... Nature Cancer 3 (5), 547-551, 2022 | 18 | 2022 |
| A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001) A Agarwal, A Khandelwal, K Pal, NK Khare, V Jadhav, M Gurjar, ... PloS one 17 (2), e0262212, 2022 | 17 | 2022 |
| A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1 N Patkar, AF Shaikh, C Kakirde, S Nathany, H Ramesh, P Bhanshe, ... Blood cancer journal 9 (10), 79, 2019 | 16 | 2019 |
| Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer VM Patil, V Noronha, A Joshi, L Nayak, N Pande, A Chandrashekharan, ... Indian journal of cancer 54 (1), 25-29, 2017 | 16 | 2017 |
| Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1 AF Shaikh, C Kakirde, C Dhamne, P Bhanshe, S Joshi, S Chaudhary, ... Leukemia & lymphoma 61 (13), 3154-3160, 2020 | 12 | 2020 |
| Optimizing acute leukemia treatment in resource-constrained settings L Nayak Cancer Research, Statistics, and Treatment 3 (2), 287-289, 2020 | 11 | 2020 |
| NARASIMHA: novel assay based on targeted RNA sequencing to identify chimeric gene fusions in hematological malignancies N Patkar, P Bhanshe, S Rajpal, S Joshi, S Chaudhary, G Chatterjee, ... Blood Cancer Journal 10 (5), 50, 2020 | 10 | 2020 |
| Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia H Jain, M Sengar, VB Goli, J Thorat, P Tembhare, D Shetty, VNA Bonda, ... Blood Advances 5 (17), 3436-3444, 2021 | 9 | 2021 |
| Real-world outcomes with generic pomalidomide in relapsed refractory multiple myeloma—experience from a Tertiary Care Cancer Center SK Bondili, B Bagal, A Zawar, P Ventrapati, J Thorat, A Gokarn, S Punatar, ... JCO Global Oncology 7, 361-367, 2021 | 9 | 2021 |
| Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India A Jain, L Nayak, UP Kulkarni, N Mehra, U Yanamandra, S Kayal, ... Blood Cancer Journal 12 (1), 2, 2022 | 7 | 2022 |
| Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab S Punatar, A Gokarn, L Nayak, A Bonda, A Chichra, S Mirgh, B Bagal, ... American Journal of Blood Research 11 (5), 528, 2021 | 5 | 2021 |
| Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant S Punatar, A Mohite, A Gokarn, L Nayak, A Bonda, K Shanmugam, ... Bone Marrow Transplantation 55 (2), 467-469, 2020 | 5 | 2020 |
| Palliative care and end-of-life measure outcomes: Experience of a tertiary care institute from South India P Adusumilli, L Nayak, V Viswanath, L Digumarti, RR Digumarti South Asian journal of cancer 7 (03), 210-213, 2018 | 5 | 2018 |
